Archives

Are You All In? Target ALS Goes “All In For ALS Awareness” with Campaign to Highlight the Community and Research Building a World Where Everyone Lives

B NEW YORK, April 30, 2026 /PRNewswire/ — For ALS Awareness Month this May, Target ALS is going “all in”: for research, for community, and… Login to continue reading Login…

Read MoreAre You All In? Target ALS Goes “All In For ALS Awareness” with Campaign to Highlight the Community and Research Building a World Where Everyone Lives

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

B – Bambusa’s lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the… Login to continue reading Login…

Read MoreBambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

NAMSA and Lexitas Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

B Sponsors gain a single, accountable partner through all stages of product development, with Lexitas’ dedicated ophthalmology expertise embedded in NAMSA’s end-to-end MedTech development platform… Login to continue reading Login…

Read MoreNAMSA and Lexitas Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development